September 29, 2022

Volume XII, Number 272

Christopher I. Halliday

With a background in chemical engineering and biochemistry Christopher I. Halliday counsels clients on strategic intellectual property (IP) issues in pharmaceutical, biotechnology, chemical, medical devices, and food science areas. He prepares and prosecutes patent applications related to new chemical entities, pharmaceutical formulations, and biologics as well as implantable medical devices, chemical processes and catalysts. Clients turn to Christopher for IP litigation advice and to develop opinions involving infringement, validity, and freedom to operate.

Articles in the National Law Review database by Christopher I. Halliday